BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  ASCO15: Pfizer Announces Palbociclib More Than Doubled Progression-Free Survival In Phase 3 Trial For Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy

  June 1, 2015

   · 

  13 min read
• Drug Development

  ASCO15: CTI BioPharma Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015

  June 1, 2015

   · 

  13 min read
• Drug Development

  OncoGenex Pharmaceuticals Inc. Announces Data From The Phase 3 SYNERGY Trial Showing A Survival Benefit With Custirsen In Patients With Poor Prognosis

  June 1, 2015

   · 

  8 min read
• Drug Development

  Pharmacyclics Release: Phase III HELIOS Study Results Show Ibrutinib (IMBRUVICA) Combination Therapy Significantly Increased Progression-Free Survival In Previously-Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients

  June 1, 2015

   · 

  15 min read
• Drug Development

  Janssen Research & Development Release: Ibrutinib (IMBRUVICA) HELIOS Interim Analysis Study Data Show Significant Reductions In Risk Of Progression Or Death In Patients With Previously-Treated Chronic Lymphocytic Leukemia

  June 1, 2015

   · 

  13 min read
• Drug Development

  Janssen Research & Development Release: Data Show Daratumumab Achieved a Pronounced Overall Response Rate As A Single-Agent With Tolerable Safety Profile In Heavily Pre-Treated Multiple Myeloma Patients

  June 1, 2015

   · 

  9 min read
• Drug Development

  ASCO15: Celsion Corporation Presents GEN-1 Immunotherapy Phase 1b Results In Recurrent Ovarian Cancer At ASCO 2015

  June 1, 2015

   · 

  6 min read
• BioMidwest

  ASCO15: GenomeDx Biosciences’s Decipher Prostate Cancer Test Is Significant Predictor Of Metastasis In Patients With Detectable PSA Following Treatment With Radiation After Prostate Surgery, According To Study Presented At ASCO 2015 Annual Meeting

  June 1, 2015

   · 

  5 min read
• BioMidwest

  St. Jude Children’s Research Hospital Release: Study Finds Changes In Treatment Have Increased Life Span For Childhood Cancer Survivors

  June 1, 2015

   · 

  5 min read
• Deals

  Actavis Completes Acquisition Of Auden Mckenzie

  June 1, 2015

   · 

  3 min read